Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry, v3.4.2, has been added to the history. The previous entry, v3.4.1, has been removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe record history shows a new entry for Revision: v3.4.1 and removal of Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe history page was updated with UI/visual changes: a glossary display option, color-coded highlights for changes, and an updated revision tag (v3.4.0).SummaryDifference0.7%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the study record history, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedNew and updated entries for Study Status appear in the history, showing changes to the trial's recruitment and status on recent dates.SummaryDifference0.3%

- Check63 days agoChange DetectedThe record history now includes Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.